Orthofix Medical Inc. (OFIX) Cash Flow Statement

As shown in SEC filings, the OCF/NI ratio has swung violently from -12.82 in 2025Q4 to +1.51 in 2026Q2, meaning operating cash flow now exceeds the net loss by 51%, but this divergence is structural rather than operational. The company has never converted reported earnings into cash because it has not generated earnings; instead, D&A averaging ~$27M per quarter and SBC averaging ~$9.5M per quarter simply bridge the gap between negative operating income and less-negative operating cash flow. Investors should treat positive OCF quarters as artefacts of non-cash add-backs rather than evidence of cash-generative operations.

Per reported figures, the last two quarters have consumed roughly $75M of free cash on a cumulative basis, erasing the cumulative FCF surplus of $15-25M accumulated during 2025. This trajectory appears inconsistent with the stable revenue growth narrative implied by recent disclosures and suggests that any near-term cash burn may be accelerating rather than stabilizing. With cumulative 10-quarter FCF now negative ~$85M, the pattern warrants scrutiny of whether the recent capex escalation (analyzed separately) is delivering commensurate revenue, or whether it represents an unproven growth bet.

As reported in SEC filings, this capex acceleration coincides with continued negative operating income and deteriorating FCF, raising the question of whether the spending is maintenance-driven or growth-oriented — a distinction that materially affects FCF quality. Historically, capex of $6-11M per quarter appeared to be broadly consistent with sustaining a ~$500M revenue base; the recent jump may indicate expansion into new capacity or integration-related investment, though the nature of the spend is not disclosed in the provided data. Investors should monitor whether subsequent quarters show revenue acceleration, as sustained 10%+ capex intensity without corresponding growth would compress FCF margins further.

Per reported figures, negative working capital movements occurred in seven of ten quarters, with the largest draws at -$83.0M... wait—$83.0K in 2024Q3 was negligible, but $45-55M outflows in 2025Q4 and 2026Q2 represent a meaningful acceleration. This pattern suggests collections may be lagging or inventory/payables management may be under pressure, consistent with the commercial overhead challenges noted in the income statement analysis. The magnitude and direction of these swings are large enough to mask underlying operating performance, meaning OCF in any single quarter is more reflective of working capital timing than underlying profitability.